GlobeNewswire Inc.T3·3mo ago
PULM Pulmatrix, Inc. Common Stock
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
PULM
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 2
- List Date
- 2014-03-21
- CIK
- 0001574235
- Next Earnings
- 2026-10-29
- Headquarters
- Framingham, MA
- Homepage
- https://www.pulmatrix.com
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 11.90% | -13.21% | -5.40% | -11.28% | 0.65% | 13.72% | -0.60% |
| Feb | 4.76% | -24.34% | -14.61% | 15.03% | 7.73% | 15.44% | 0.67% |
| Mar | -20.83% | 19.41% | -13.35% | -8.62% | -14.51% | -31.75% | -11.61% |
| Apr | -33.10% | -23.73% | -1.69% | 9.20% | 7.74% | -4.55% | -7.69% |
| May | -4.45% | 1.94% | -4.56% | -1.06% | 37.64% | 7.75% | 6.21% |
| Jun | 11.60% | -8.38% | -1.47% | -1.53% | -19.58% | 22.30% | 0.49% |
| Jul | -17.18% | -9.47% | -3.81% | 10.71% | -14.83% | 2.35% | -5.37% |
| Aug | -2.37% | -0.23% | -11.99% | -11.91% | -7.56% | -15.52% | -8.26% |
| Sep | -3.15% | -17.93% | -13.62% | 3.13% | 2.10% | -0.33% | -4.97% |
| Oct | 12.49% | -3.91% | -8.70% | 4.27% | 0.71% | -6.49%* | -0.27% |
| Nov | -25.64% | 2.75% | 8.99% | 211.74% | -8.81% | -- | 37.81% |
| Dec | -29.95% | 4.86% | -7.92% | 10.09% | -51.20% | -- | -14.82% |
| Total | -69.62% | -57.13% | -56.64% | 257.09% | -60.17% | -9.18% | 0.72% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1.46
SMA 50: $1.49
SMA 200: $1.73
Current: $1.44
EMA 12: $1.45
EMA 26: $1.47
MACD: -0.0197 | Signal: 0.0038
BEARISH
ADX (14): 22.79
WEAK TREND
+DI: 21.76
−DI: 9.39
Momentum Oscillators
RSI (14): 47.58
NEUTRAL
Stoch %K: 39.44
Stoch %D: 48.25
Williams %R: -63.03
Volume & Volatility
BB Upper: $1.59
BB Lower: $1.34
NEUTRAL
OBV: 22,226,732
Vol SMA 20: 21,298
Vol ROC: -25.62%
ATR: $0.11
True Range: $0.09
HV 20: 70.2%
HV 30: 75.0%
HV 60: 63.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-25T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: PULM
Executive Summary
Overall Assessment: NEUTRAL (6/10)
Key Drivers:
- Technical indicators suggest a neutral trend, with price hovering around the middle Bollinger Band.
- Low volatility indicates reduced risk.
Primary Risks:
- Negative news sentiment could lead to a breakdown in support levels and potentially trigger a bearish momentum signal.
Investment Thesis: PULM's current technical setup suggests a consolidation phase, which may continue unless catalysts emerge. The low volatility environment reduces the potential for significant price movements.
Recent News Sentiment Impact: No recent news available, but the lack of market-moving headlines contributes to the neutral sentiment.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): NEUTRAL, Medium-term (1-3 months): BEARISH, Long-term (3-12 months): BULLISH
Support/Resistance Levels:
- Upper Bollinger Band: $5.23
- Middle Bollinger Band: $4.80
- Lower Bollinger Band: $4.38
- SMA 20: $4.80
- EMA 12: $4.81
Momentum Signals: RSI (14): 47.82 (neutral) MACD: -0.04 / Signal: 0.02 / Histogram: -0.06 (bearish)
Volume Analysis: Volume trends and institutional interest signals:
- Volume SMA 20: 18283.50
- On-Balance Volume (OBV): 23366405.00
- Volume Rate of Change: 89.42%
News & Sentiment Analysis
Recent Headlines Summary: No recent news available.
Sentiment Assessment: Neutral, as there is no significant market-moving news.
Catalyst Identification: None identified, but upcoming earnings on 2025-11-06 could be a catalyst for price movement.
Market Narrative: The neutral sentiment aligns with the technical signals, indicating a consolidation phase.
Risk & Volatility Assessment
Beta Interpretation: Beta: 0.52 (vs SPY), indicating low volatility relative to the market.
Volatility Regime: Low volatility, stock moves less than the market.
Options Market Signals: No options data available.
Downside Protection: Support levels and risk management considerations:
- Lower Bollinger Band: $4.38
- SMA 20: $4.80
Market Context & Positioning
Sector Performance: Relative strength vs sector/market: NEUTRAL.
Institutional Activity: Volume patterns suggesting institutional interest signals:
- Institutional traders are not strongly interested in the stock, as reflected by the low volume and OBV.
Correlation Analysis: How stock moves relative to market (R-squared interpretation): 0.08, indicating a relatively weak correlation.
Relative Valuation: Position within trading range: NEUTRAL.
Key Levels & Action Items
Critical Price Levels: Support/resistance levels:
- Upper Bollinger Band: $5.23
- Middle Bollinger Band: $4.80
- Lower Bollinger Band: $4.38
- SMA 20: $4.80
- EMA 12: $4.81
Breakout/Breakdown Levels: Technical levels that could trigger significant moves:
- Breakout above the upper Bollinger Band: Bullish momentum signal.
- Breakdown below the lower Bollinger Band: Bearish momentum signal.
Time-Sensitive Catalysts: Earnings on 2025-11-06, which may impact price movement.
Risk Management: Stop-loss levels and position sizing considerations:
- Set stop-loss orders at $4.38 (lower Bollinger Band) for long positions.
- Consider reducing position size or taking profits if the stock breaks below SMA 20 or EMA 12.
Generated
News
All PULM news →
GlobeNewswire Inc.T3·4mo ago
Zacks Investment ResearchT3·38mo ago
Zacks Investment ResearchT3·39mo ago
Zacks Investment ResearchT3·39mo ago
BenzingaT3·50mo ago
Zacks Investment ResearchT3·54mo ago
Zacks Investment ResearchT3·54mo ago
Zacks Investment ResearchT3·60mo ago
Zacks Investment ResearchT3·60mo ago
Showing 1–10 of 23
Page 1 of 3
PULM Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 0.0338
Alpha: -79.20%
Correlation: 0.0049
R-Squared: 0.0%
Stock Volatility: 87.4%
Market Volatility: 12.8%
Analysis Details
Benchmark: SPY
Data Points: 250
Period: 252 trading days
Data Points: 250
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own PULM
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $209K | #2874 of 3138 | +12.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PULM Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
PULM Insider Trading (Form 4)
Latest: 2023-01-30Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2023-01-30 | Michael J Higgins | Director | Grant (A) | +2,436 opt | — | EDGAR | |
| 2023-01-30 | Richard P. Batycky | Director | Grant (A) | +1,700 opt | — | EDGAR | |
| 2023-01-30 | Margaret Wasilewski | Chief Medical Officer | Grant (A) | +11,400 opt | — | EDGAR | |
| 2023-01-30 | Todd Bazemore | Director | Grant (A) | +1,700 opt | — | EDGAR | |
| 2023-01-30 | Michelle Siegert | Vice President, Finance | Grant (A) | +9,900 opt | — | EDGAR | |
| 2023-01-30 | Christopher Cabell | Director | Grant (A) | +1,700 opt | — | EDGAR | |
| 2023-01-30 | Teofilo David Raad | Chief Executive Officer | Grant (A) | +34,900 opt | — | EDGAR | |
| 2023-01-30 | Anand Varadan | Director | Grant (A) | +1,700 opt | — | EDGAR | |
| 2022-03-03 | Margaret Wasilewski | Chief Medical Officer | Grant (A) | +21,060 opt | — | EDGAR | |
| 2022-01-31 | Richard P. Batycky | Director | Grant (A) | +22,100 opt | — | EDGAR | |
| 2022-01-31 | Michael J Higgins | Director | Grant (A) | +36,833 opt | — | EDGAR | |
| 2022-01-31 | Christopher Cabell | Director | Grant (A) | +22,100 opt | — | EDGAR | |
| 2022-01-28 | Todd Bazemore | Director | Grant (A) | +22,100 opt | — | EDGAR | |
| 2022-01-28 | Michelle Siegert | Vice President, Finance | Grant (A) | +184,300 opt | — | EDGAR | |
| 2022-01-28 | Teofilo David Raad | Chief Executive Officer | Grant (A) | +750,000 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
PULM Board & Officers
As of SEC filings through Jan 30, 2023The company's insiders have not filed since Jan 30, 2023; this reflects that date.
Directors 18
- Gregory M French · since Mar 21, 2014
- Hojabr Alimi · since Mar 21, 2014
- Richard K Conley · since Mar 21, 2014
- Akihisa Akao · since Feb 27, 2015
- David Maki · since Jun 15, 2015
- Kurt Graves · since Jun 15, 2015
- Michael J Higgins · since Jun 15, 2015
- Robert W. Clarke · since Jun 15, 2015
- Scott M Rocklage · since Jun 15, 2015
- Terrance McGuire · since Jun 15, 2015
- Mark T Iwicki · since Dec 8, 2015
- Matthew L Sherman · since Sep 29, 2016
- Amit Munshi · since Jun 13, 2017
- Teofilo David Raad · listed since May 2019
- Richard P. Batycky · since Nov 1, 2019
- Christopher Cabell · since Jun 23, 2020
- Todd Bazemore · since Oct 1, 2020
- Anand Varadan · since Jul 26, 2021
Officers 10
- Hojabr Alimi · CEO and Chief Science Officer · since Mar 21, 2014
- Robert W. Clarke · Chief Executive Officer · since Jun 15, 2015
- Teofilo David Raad · Chief Executive Officer · listed since May 2019
- Michelle Siegert · Vice President, Finance · since Nov 13, 2019
- Sameer Harish · Chief Financial Officer · since Mar 21, 2014
- William E. Duke · Chief Financial Officer · since Jun 24, 2015
- Peter Ludlum · Interim CFO · since Apr 18, 2022
- David L. Hava · Chief Scientific Officer · since Jun 15, 2015
- James M. Roach · Chief Medical Officer · since Nov 3, 2017
- Margaret Wasilewski · Chief Medical Officer · since Mar 1, 2022
10% owners 11
- Jonathan A Flint · since Jun 15, 2015
- Oculus Innovative Sciences, Inc. (entity) · since Mar 26, 2014
- Polaris Venture Management Co IV LLC (entity) · since Jun 15, 2015
- Polaris Venture Management Co. V, L.L.C. (entity) · since Jun 15, 2015
- Polaris Venture Partners Entrepreneurs Fund IV LP (entity) · since Jun 15, 2015
- Polaris Venture Partners Entrepreneurs' Fund V, L.P. (entity) · since Jun 15, 2015
- Polaris Venture Partners Founders' Fund V, L.P. (entity) · since Jun 15, 2015
- Polaris Venture Partners IV LP (entity) · since Jun 15, 2015
- Polaris Venture Partners Special Founders' Fund V, L.P. (entity) · since Jun 15, 2015
- Polaris Venture Partners V, L.P. (entity) · since Jun 15, 2015
- Terrance McGuire · since Jun 15, 2015
Changes in the last 10 years (19)
| Apr 18, 2022 | Peter Ludlum became Interim CFO |
| Mar 1, 2022 | Margaret Wasilewski became Chief Medical Officer |
| Jul 26, 2021 | Anand Varadan became a director |
| Oct 1, 2020 | Todd Bazemore became a director |
| Sep 1, 2020 | Steven Gillis reported in an SEC filing no longer being a director |
| Jun 23, 2020 | Christopher Cabell became a director |
| Nov 13, 2019 | Michelle Siegert became Vice President, Finance |
| Nov 1, 2019 | Richard P. Batycky became a director |
| May 20, 2019 | Teofilo David Raad listed as Chief Executive Officer (previously Chief Business Officer) in SEC filings |
| May 20, 2019 | Teofilo David Raad first listed as a director in an SEC filing |
| Apr 12, 2018 | Robert Nelsen reported in an SEC filing no longer being a 10% owner |
| Apr 12, 2018 | Keith Crandell reported in an SEC filing no longer being a 10% owner |
| Apr 12, 2018 | Clinton Bybee reported in an SEC filing no longer being a 10% owner |
| Apr 12, 2018 | Arch Venture Fund VII LP reported in an SEC filing no longer being a 10% owner |
| Apr 12, 2018 | ARCH Venture Partners VII, LLC reported in an SEC filing no longer being a 10% owner |
| Apr 12, 2018 | ARCH Venture Partners VII, L.P. reported in an SEC filing no longer being a 10% owner |
| Nov 3, 2017 | James M. Roach became Chief Medical Officer |
| Jun 13, 2017 | Amit Munshi became a director |
| May 1, 2017 | Teofilo David Raad became Chief Business Officer |
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
1 ETF hold PULM
1 shown · $49.09K total exposure
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $49,087 | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.